Environmental science and pollution research international

Frontiers in pharmacology

Nano letters

international journal of nanomedicine

Advanced drug delivery reviews

acs nano

nanomedicine (london, england)

Journal of colloid and interface science

Medicina (Kaunas, Lithuania)

Journal of visualized experiments : JoVE

colloids and surfaces b, biointerfaces

Applied microbiology and biotechnology

Frontiers in bioengineering and biotechnology

Cancers

Frontiers in immunology

Revista da Sociedade Brasileira de Medicina Tropical

anatomical record (hoboken, nj : 2007)

[1] A Tunable Nanoplatform of Nanogold Functionalised with Angiogenin Peptides for Anti-Angiogenic Therapy of Brain Tumours.

[2] Advances in nanomedical applications: diagnostic, therapeutic, immunization, and vaccine production.

[3] Nanomedicines for developing cancer nanotherapeutics: from benchtop to bedside and beyond.

[4] Targeted brain delivery nanoparticles for malignant gliomas.

[5] Stacking as a Key Property for Creating Nanoparticles with Tunable Shape: The Case of Squalenoyl-Doxorubicin.

[6] Dendrimer based theranostic nanostructures for combined chemo- and photothermal therapy of liver cancer cells in vitro.

[7] Nanomedicine: Insights from a Bibliometrics-Based Analysis of Emerging Publishing and Research Trends.

[8] Editorial: Interaction of Nanomaterials with the Immune System: Role in Nanosafety and Nanomedicine.

[9] Cardiac tamponade in a patient with severe dengue fever.

[10] Recalcitrant Issues and New Frontiers in Nano-Pharmacology.

[11] Orientation of the round window membrane: A normative study of inner ear anatomical orientation using 2D projections of 3D volumes.

[12] Four-Dimensional CT Analysis Using Sequential 3D-3D Registration.

[13] Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells.

[14] Energy Conversion-Based Nanotherapy for Rheumatoid Arthritis Treatment.

[15] emerging insights into barriers to effective brain tumor therapeutics

[16] fucoidans in nanomedicine

[17] antimicrobial properties of nanomolecules: potential candidates as antibiotics in the era of multi-drug resistance

[18] oligonucleotide aptamers: new tools for targeted cancer therapy

[19] new trends on antineoplastic therapy research: bullfrog (rana catesbeiana shaw) oil nanostructured systems

[20] nanotechnology; its significance in cancer and photodynamic therapy

[21] emerging nanomedicine therapies to counter the rise of methicillin-resistant staphylococcus aureus

[22] interfacing graphene-based materials with neural cells

[23] Drug delivery approaches for HuR-targeted therapy for lung cancer.

[24] Correction: An in vitro examination of the antioxidant, cytoprotective and anti-inflammatory properties of chrysin-loaded nanofibrous mats for potential wound healing applications (Artificial Cells, Nanomedicine, and Biotechnology, (2018), 46, 4, (706-716), 10.1080/21691401.2017.1337022)

[25] A UHPLC–MS/MS method coupled with simple and efficient alkaline hydrolysis for free and total determination of conjugate nanomedicine: Pharmacokinetic and biodistribution study of poly (L-glutamic acid)-graft-methoxy poly (ethylene glycol)/combretastatin A4

[26] ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology

[27] Tamoxifen and Sulphoraphane for the breast cancer management: A synergistic nanomedicine approach.

[28] A tumor-targeting nanomedicine carrying the p53 gene crosses the blood–brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma

[29] Nanomedicines for developing cancer nanotherapeutics: from benchtop to bedside and beyond.

[30] PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution.

[31] Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo

[32] The synthesis and application of nano doxorubicin-indocyanine green matrix metalloproteinase-responsive hydrogel in chemophototherapy forhead and neck squamous cell carcinoma (International Journal of Nanomedicine, 2019, 14, (623-638), 10.2147/IJN.S191069)

[33] Magnetic Nanoparticles: Current Trends and Future Aspects in Diagnostics and Nanomedicine.

[34] Design and Synthesis of Gold-Gadolinium-Core-Shell Nanoparticles as Contrast Agent: a Smart Way to Future Nanomaterials for Nanomedicine Applications.

[35] Nanomedicine: Insights from a Bibliometrics-Based Analysis of Emerging Publishing and Research Trends.

[36] Editorial: Interaction of Nanomaterials with the Immune System: Role in Nanosafety and Nanomedicine.

[37] Polymeric Core-Shell Combinatorial Nanomedicine for Synergistic Anticancer Therapy.

[38] Delivery Systems in Wound Healing and Nanomedicine

[39] Biocompatibility assessment of sub-5 nm silica-coated superparamagnetic iron oxide nanoparticles in human stem cells and in mice for potential application in nanomedicine.

[40] Qualitative and quantitative analysis of patent data in nanomedicine for bridging the gap between research activities and practical applications

[41] Sequential Intra-Intercellular Delivery of Nanomedicine for Deep Drug-Resistant Solid Tumor Penetration.

[42] Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.

[43] Precision Nanomedicine Vol. 2, Issue 3 Table of Contents

[44] nanomedicine

[45] the potential of zebrafish as a model organism for improving the translation of genetic anticancer nanomedicines

[46] nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments

[47] integrating microtissues in nanofiber scaffolds for regenerative nanomedicine

[48] fucoidans in nanomedicine

[49] theranostic nanomedicine: potential therapeutic epitome

[50] a review of drug delivery systems based on nanotechnology and green chemistry: green nanomedicine

[51] bio-inspired/-functional colloidal core-shell polymeric-based nanosystems: technology promise in tissue engineering, bioimaging and nanomedicine

[52] emerging nanomedicine therapies to counter the rise of methicillin-resistant staphylococcus aureus

[53] Reprogramming of radiation-deteriorated TME by liposomal nanomedicine to potentiate radio-immunotherapy.